Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04795752 · ClinicalTrials.gov registry record · NA
Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)
A NA study, sponsored by Sight Sciences.
- Completed
- Registry status
- NA
- Development phase
- 345
- Enrollment target
NCT04795752: Completed NA study, sponsored by Sight Sciences.
NCT04795752 is a NA study that has completed, run by Sight Sciences. The registered enrollment target is 345 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04795752, a NA study, has completed, sponsored by Sight Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 345 participants
- Enrollment target
Study Summary
To demonstrate the safety and effectiveness of TearCare® procedures compared to Restasis® to treat the signs and symptoms of dry eye disease in adult patients.
Primary Outcome
Change in Tear Break-Up Time (TBUT) from baseline to month 6
Interventions
- DEVICE TearCare System
- DRUG Cyclosporine Ophthalmic 0.05% Ophthalmic Emulsion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 345 participants |
| Start Date | 2021-04-28 |
| Est. Completion | 2024-09-23 |
| Phase | NA |
What the finished NCT04795752 record still lists
NCT04795752 is an interventional study that assigns participants to a tested intervention. The registered 345 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which TearCare System is the first listed.
NCT04795752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04795752 about?
NCT04795752 is a clinical study titled "Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)". To demonstrate the safety and effectiveness of TearCare® procedures compared to Restasis® to treat the signs and symptoms of dry eye disease in adult patients.
What is the current status of trial NCT04795752?
This trial is currently completed. It is a NA study. The enrollment target is 345 participants. The study started on 2021-04-28. Estimated completion is 2024-09-23.
What interventions are being tested in trial NCT04795752?
The interventions under investigation include: TearCare System (DEVICE), Cyclosporine Ophthalmic 0.05% Ophthalmic Emulsion (DRUG).
Who is sponsoring clinical trial NCT04795752?
This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04795752's enrollment target sits among peer trials
345 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03972657 · 345 participants · Phase 1
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- NCT05107674 · 345 participants · Phase 1
A Study of NX-1607 in Adults With Advanced Malignancies
- NCT05700279 · 345 participants · NA
Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset
- NCT05781100 · 345 participants · NA
Investigating Baby Behavior and Family Technology Use Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI